ABSTRACT
Rapid and sensitive screening tools for SARS-CoV-2 infection are essential to limit the spread of COVID-19 and to properly allocate national resources. Here, we developed a new point-of-care, non-contact thermal imaging tool to detect COVID-19, based on image-processing algorithms and machine learning analysis. We captured thermal images of the back of individuals with and without COVID-19 using a portable thermal camera that connects directly to smartphones. Our novel image processing algorithms automatically extracted multiple texture and shape features of the thermal images and achieved an area under the curve (AUC) of 0.85 in detecting COVID-19 with up to 92% sensitivity. Thermal imaging scores were inversely correlated with clinical variables associated with COVID-19 disease progression. We show, for the first time, that a hand-held thermal imaging device can be used to detect COVID-19. Non-invasive thermal imaging could be used to screen for COVID-19 in out-of-hospital settings, especially in low-income regions with limited imaging resources.
HIGHLIGHTS
Automated processing of thermal images of the back can be used to detect COVID-19 with up to 92% sensitivity.
The extracted texture features of the thermal image are associated with COVID-19 disease progression and lung injury.
A portable thermal camera that connects directly to smartphones can be used to detect COVID-19.
Non-invasive thermal imaging could be used to screen for COVID-19 in out-of-hospital settings and regions with limited imaging resources.
Competing Interest Statement
OH, RYB, NR, YZ, ZOB, NNS, and JL applied for a patent on thermal imaging for detection of disease via Afeka Tel Aviv Academic College of Engineering, Tel Aviv University, and Sheba Medical Center.
Funding Statement
This study was supported by a grant from the Israel Innovation Authority and a grant from the Nicholas and Elizabeth Slezak Super Center for Cardiac Research and Biomedical Engineering at Tel Aviv University.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the institutional review boards of each participating medical center or academic institution including the Sheba Medical Center, the Tel Aviv Sourasky Medical Center, and the Afeka Tel Aviv Academic College of Engineering.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The anonymized datasets generated during this study are available from the corresponding author upon reasonable request. The raw thermal images of the patients will not be available due to patient privacy regulations.
